BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21539866)

  • 1. C/EBPα and C/EBPβ binding proteins modulate hepatocyte apoptosis through iNOS signaling pathway.
    Wang K; Brems JJ; Gamelli RL; Holterman AX
    Biochim Biophys Acta; 2011 Aug; 1813(8):1395-403. PubMed ID: 21539866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes.
    Bucher BT; Feng X; Jeyabalan G; Zhang B; Shao L; Guo Z; Geller DA
    J Surg Res; 2007 Mar; 138(1):15-21. PubMed ID: 17174337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iNOS/NO signaling regulates apoptosis induced by glycochenodeoxycholate in hepatocytes.
    Wang K; Brems JJ; Gamelli RL; Holterman AX
    Cell Signal; 2011 Oct; 23(10):1677-85. PubMed ID: 21693187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.
    Bristol JA; Morrison TE; Kenney SC
    Mol Immunol; 2009 Aug; 46(13):2706-13. PubMed ID: 19523687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and DNA-binding activity of C/EBPalpha and C/EBPbeta in human liver and differentiated primary hepatocytes.
    Ferrini JB; Rodrigues E; Dulic V; Pichard-Garcia L; Fabr JM; Blanc P; Maurel P
    J Hepatol; 2001 Aug; 35(2):170-7. PubMed ID: 11580138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes.
    Sakitani K; Nishizawa M; Inoue K; Masu Y; Okumura T; Ito S
    Genes Cells; 1998 May; 3(5):321-30. PubMed ID: 9685183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β.
    Yamauchi Y; Okuyama T; Ishii T; Okumura T; Ikeya Y; Nishizawa M
    J Nat Med; 2019 Mar; 73(2):353-368. PubMed ID: 30467676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis.
    Tang QQ; Zhang JW; Daniel Lane M
    Biochem Biophys Res Commun; 2004 May; 318(1):213-8. PubMed ID: 15110775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 influences Smad2 expression via the transcription factor C/EBPα and C/EBPβ during bovine myoblast differentiation.
    Zhang L; Ning Y; Li P; Zan L
    Arch Biochem Biophys; 2019 Aug; 671():235-244. PubMed ID: 31071302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
    Abdou HS; Atlas E; Haché RJ
    Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gomisin N in the herbal drug gomishi (Schisandra chinensis) suppresses inducible nitric oxide synthase gene via C/EBPβ and NF-κB in rat hepatocytes.
    Takimoto Y; Qian HY; Yoshigai E; Okumura T; Ikeya Y; Nishizawa M
    Nitric Oxide; 2013 Jan; 28():47-56. PubMed ID: 23085209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
    Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
    J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer binding protein-mediated regulation of TGFβ receptor 2 expression determines the hepatoblast fate decision.
    Takayama K; Kawabata K; Nagamoto Y; Inamura M; Ohashi K; Okuno H; Yamaguchi T; Tashiro K; Sakurai F; Hayakawa T; Okano T; Furue MK; Mizuguchi H
    Development; 2014 Jan; 141(1):91-100. PubMed ID: 24284203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities.
    Guerzoni C; Ferrari-Amorotti G; Bardini M; Mariani SA; Calabretta B
    Cell Cycle; 2006 Jun; 5(12):1254-7. PubMed ID: 16760662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.
    Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD
    Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P; Singh NN; Salter RC; Ramji DP
    Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.
    Ranjan R; Thompson EA; Yoon K; Smart RC
    Oncogene; 2009 Sep; 28(36):3235-45. PubMed ID: 19581927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin signaling is regulated through nuclear factor-kappa B pathway during glycochenodeoxycholate-induced hepatocyte apoptosis.
    Wang K; Brems JJ; Gamelli RL; Holterman AX
    Biochim Biophys Acta; 2010 Dec; 1803(12):1368-75. PubMed ID: 20816704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.